Arkray, Inc.

Lion Corporation

Riichi Maki

Akira Uchiyama

Naho Suzuki

Akio Okubo

Kei Kurita

Seiji Satake

Kouichi Saito

Eiji Nishinaga

Mikio Miyake

Chiyoko Uchiyama

Isao Fukuta

Tetsu Fukasawa

Eriko Fukushima

Haruhiko Fujikawa

It is an object of the present invention to provide a marker substance capable of accurately determining a risk of developing metabolic syndrome in vivo. That is, the present invention provides the followings: a marker peptide for determining the risk of developing the metabolic syndrome; an antibody or an aptamer bound to the marker peptide for determining the risk of developing the metabolic syndrome; a microarray in which the antibody or the aptamer bound to the marker peptide for determining the risk of developing the metabolic syndrome has been immobilized on a carrier; a method for determining the risk of developing the metabolic syndrome, comprising measuring an amount or the presence or absence of the marker peptide for determining the risk of developing the metabolic syndrome in a biological sample collected from a subject; and a kit for determining the risk of developing the metabolic syndrome, comprising the antibody or the aptamer or comprising the microarray.

Marker peptide for determining risk of developing metabolic syndrome, and use thereof

A method of determining the condition of the oral cavity in a subject is provided by using an analytical tool comprising the following (A), (B), and (C):

Analytical tool and method for determining a condition of an oral cavity

Growing community of inventors

Tokyo, Japan

Riichi Maki